Immunocompromised patients demonstrate a wide variety of idiopathic cutaneous and mucosal lesions including dermatitis, gastrointestinal and genital tract ulcerations, and recurrent aphthous stomatitis. One objective of this research program is to evaluate the pathogenesis of mucosal inflammation associated with immune dysregulation in HIV-infected patients with aphthous lesions. A randomized, controlled clinical trial using topical thalidomide was initiated which serves as a vehicle for several lines of inquiry directed towards investigating the pathogenesis and treatment of oral aphthous ulcers, which are spontaneous, recurrent mucosal ulcerations of unknown etiology, and which are persistent and debilitating in persons with HIV/AIDS. In addition to mucosal lesions, cutaneous lesions may also become chronic and debilitating, and new efforts are focusing on therapeutic intervention in chronic nonhealing wounds. The delayed healing response in the aged, characterized by a predominance of neutrophils and excess elastase, can be mimicked in animal models including ovariectomized rodents and secretory leukocyte protease inhibitor(SLPI) knockout mice. Using these models of cutaneous and oral wounds, delayed healing can be reversed by the topical application of estrogen, SLPI and synthetic fibronectin peptides. Based on the successful application of estrogen topically in reversing human nnnonhealing wounds, other novel approaches for inhibiting the persistent leukocyte recruitment and overabundant elastase released at the inflammatory site will be evaluated for their efficacy in facilitating the healing process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000691-04
Application #
6507213
Study Section
(OIIB)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Warburton, Gary; Nikitakis, Nikolaos G; Roberson, Patrick et al. (2007) Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 65:475-84
Wahl, Sharon M (2007) Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 19:55-62
Wang, Xiao-Min; Wu, Tian-Xia; Hamza, May et al. (2007) Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 128:136-47
Riley, E M; Wahl, S; Perkins, D J et al. (2006) Regulating immunity to malaria. Parasite Immunol 28:35-49
Wahl, Sharon M; Wen, Jie; Moutsopoulos, Niki (2006) TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 213:213-27
Skaleric, Uros; Gaspirc, Boris; McCartney-Francis, Nancy et al. (2006) Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease. Infect Immun 74:7010-3
Wahl, Sharon M; Wen, Jie; Moutsopoulos, Niki M (2006) The kiss of death: interrupted by NK-cell close encounters of another kind. Trends Immunol 27:161-4
Peng, Gang; Lei, Ke Jian; Jin, Wenwen et al. (2006) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203:41-6
Moutsopoulos, N M; Angelov, N; Sankar, V et al. (2006) Immunological consequences of thalidomide treatment in Sjogren's syndrome. Ann Rheum Dis 65:112-4
Vazquez, Nancy; Greenwell-Wild, Teresa; Marinos, Nancy J et al. (2005) Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol 79:4479-91

Showing the most recent 10 out of 32 publications